Chris Chandler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chris Chandler has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Samantha Banbury
London Metropolitan University
4 shared publications - Joanne Lusher
Oral Health Initiative, Center for Reproductive and Population Health Studies, Nigerian Institute of Medical Research
3 shared publications - John J.D. Turner
Department of Psychological Sciences, University of East London, United Kingdom
2 shared publications - Simon Erridge
Medical Cannabis Research Group Imperial College London London UK
2 shared publications - Andrea Cercek
Memorial Sloan Kettering Cancer Center
1 shared publication - Andrew Simpson
Department of Psychology, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, UK
1 shared publication
Latest Publications
- Open Access
A Preliminary Investigation into the Use of Cannabis Suppositories and Online Mindful Compassion for Improving Sexual Function Among Women Following Gynaecological Cancer Treatment
Background and Objectives: The impact of gynaecological cancer and its treatments on sexual intimacy can be profound on female sexuality. However, very few registered clinical trials have addressed sexual intimacy among this cohort. Materials and Methods: This preliminary randomised control trial (RCT) and content analysis assessed the effectiveness of a brief online mindful compassion group intervention adjunct with cannabis suppositories. Eighty-three participants aged between 18 and 50+ years who were at least six months post-cancer treatment were randomly allocated to one of four groups, depending on whether they were already using cannabis suppositories. These included a cannabis-only group (CO), a mindful-compassion group (MC), a combined mindful-compassion and cannabis suppositories group (COCM) and a care-as-usual group (CAU). Measurements of sexual function, sexual self-efficacy, mindful compassion, well-being and quality of life were taken at weeks 0, 4 and 12. Results: Sexual function, including arousal, lubrication and orgasms, improved for both the MC p = 0.002 and COCM p ≤ 0.001 groups; in addition, sexual pain was reduced in the COCM p = 0.008 and CO p ≤ 0.001 groups compared to the CAU and MC groups, where p ≥ 0.05. Feedback suggested that cannabis mediated the effects of mindful compassion and supported well-being, sexual self-efficacy, and quality of life. Participants also voiced a preference for cannabis suppositories when using dilators as part of their treatment and the use of sex toys instead of dilators, suggesting that dilators had negatively impacted their sexuality. Conclusions: These preliminary and exploratory outcomes look promising and provide a foundation for future research to develop varied healthcare options to improve mental health service delivery and quality of life for this cohort.
Open AccessA Preliminary Investigation into the Use of Cannabis Suppositories and Online Mindful Compassion for Improving Sexual Function Among Women Following Gynaecological Cancer Treatment
Background and Objectives: The impact of gynaecological cancer and its treatments on sexual intimacy can be profound on female sexuality. However, very few registered clinical trials have addressed sexual intimacy among this cohort. Materials and Methods: This preliminary randomised control trial (RCT) and content analysis assessed the effectiveness of a brief online mindful compassion group intervention adjunct with cannabis suppositories. Eighty-three participants aged between 18 and 50+ years who were at least six months post-cancer treatment were randomly allocated to one of four groups, depending on whether they were already using cannabis suppositories. These included a cannabis-only group (CO), a mindful-compassion group (MC), a combined mindful-compassion and cannabis suppositories group (COCM) and a care-as-usual group (CAU). Measurements of sexual function, sexual self-efficacy, mindful compassion, well-being and quality of life were taken at weeks 0, 4 and 12. Results: Sexual function, including arousal, lubrication and orgasms, improved for both the MC p = 0.002 and COCM p ≤ 0.001 groups; in addition, sexual pain was reduced in the COCM p = 0.008 and CO p ≤ 0.001 groups compared to the CAU and MC groups, where p ≥ 0.05. Feedback suggested that cannabis mediated the effects of mindful compassion and supported well-being, sexual self-efficacy, and quality of life. Participants also voiced a preference for cannabis suppositories when using dilators as part of their treatment and the use of sex toys instead of dilators, suggesting that dilators had negatively impacted their sexuality. Conclusions: These preliminary and exploratory outcomes look promising and provide a foundation for future research to develop varied healthcare options to improve mental health service delivery and quality of life for this cohort.
- Open Access
- 7 August 2024
- Published by MDPI AG in Psychoactives
- Vol. 3 (3) , 384-399
A Preliminary Study Looking at the Use of Mindful Compassion and Cannabis Suppositories for Anodyspareunia among Men Who Have Sex with Men (MSM)
Research on the use of cannabis rectal suppositories for analgesia is limited. Few trials have evaluated the combined use of mindfulness and cannabis suppositories for anodyspareunia in men who have sex with men (MSM). This preliminary study, including a randomised control trial (RCT) and content analysis, assessed the effectiveness of an online mindful-compassion and cannabis suppository intervention among 52 British MSM (aged 18–50) who predominantly identified as bottoms (recipients of anal sex). Participants were randomly allocated to one of four groups based on whether they were using cannabis suppositories: adjunct cannabis suppository and mindful-compassion (CSMF), cannabis suppository only (CS), mindful compassion only (MF) and care as usual/control (CAU). Assessments measuring mindful compassion, sexual functioning, sexual self-efficacy, well-being, and anodyspareunia levels were completed at weeks 0, 4, and 12. Anodyspareunia levels were lower in the CSMF group compared to the other groups (CS/MF/CAU), p = 0.031. Feedback revealed that participants felt mindful compassion potentiated the effects of cannabis suppositories during sexual intimacy, reducing pain and enhancing sexual self-efficacy, sexual functioning, and well-being. This preliminary study warrants larger-scale investigation to establish the role of cannabis suppositories and mindful compassion in reducing anodyspareunia.
- 7 August 2024
- Published by MDPI AG in Psychoactives
- Vol. 3 (3) , 384-399
Open AccessA Preliminary Study Looking at the Use of Mindful Compassion and Cannabis Suppositories for Anodyspareunia among Men Who Have Sex with Men (MSM)
Research on the use of cannabis rectal suppositories for analgesia is limited. Few trials have evaluated the combined use of mindfulness and cannabis suppositories for anodyspareunia in men who have sex with men (MSM). This preliminary study, including a randomised control trial (RCT) and content analysis, assessed the effectiveness of an online mindful-compassion and cannabis suppository intervention among 52 British MSM (aged 18–50) who predominantly identified as bottoms (recipients of anal sex). Participants were randomly allocated to one of four groups based on whether they were using cannabis suppositories: adjunct cannabis suppository and mindful-compassion (CSMF), cannabis suppository only (CS), mindful compassion only (MF) and care as usual/control (CAU). Assessments measuring mindful compassion, sexual functioning, sexual self-efficacy, well-being, and anodyspareunia levels were completed at weeks 0, 4, and 12. Anodyspareunia levels were lower in the CSMF group compared to the other groups (CS/MF/CAU), p = 0.031. Feedback revealed that participants felt mindful compassion potentiated the effects of cannabis suppositories during sexual intimacy, reducing pain and enhancing sexual self-efficacy, sexual functioning, and well-being. This preliminary study warrants larger-scale investigation to establish the role of cannabis suppositories and mindful compassion in reducing anodyspareunia.
- Open Access
- 1 July 2024
- Published by UNED - Universidad Nacional de Educacion a Distancia in Revista de Psicoterapia
- Vol. 35 (128) , 4-12
The impact of a brief online mindfulness intervention to support erectile dysfunction in African Caribbean men: a pilot waitlist controlled randomised controlled trial and content analysis.
Limited clinical trials have evaluated the effectiveness of mindfulness for sexual functioning in men and the existing studies have targeted white male populations. The present study aimed to evaluate the effectiveness of a Mindfulness-Based Cognitive Intervention (MBCI) for erectile dysfunction (ED) in n=68 African Caribbean men aged 31–50 years old A mixed methods approach was adopted to establish the feasibility of a brief online MBCI, using a waitlist-controlled randomised trial with an experimental and delayed group and a content analysis. Participants completed a series of assessments measuring ED, sexual self-efficacy, well-being, and cognitive mindfulness at weeks 0, 4, and 12 (follow-up). They also completed a series of feedback questions on their experiences of the intervention at weeks 0, 4, and 12. Higher levels of erectile functioning, cognitive mindfulness, sexual self-efficacy, and well-being were reported post-intervention and at the 12-week follow-up. A content analysis of participant feedback responses yielded favourable outcomes, with participants suggesting that they continue to engage in cognitive mindfulness exercises to support them in “having better sex”. This research is the first to look at MCBI in African-Caribbean males with ED and demonstrated the effectiveness of this online intervention; however, it warrants replication with a larger group of ethnically and culturally diverse participants with ED.
- 1 July 2024
- Published by UNED - Universidad Nacional de Educacion a Distancia in Revista de Psicoterapia
- Vol. 35 (128) , 4-12
Open AccessThe impact of a brief online mindfulness intervention to support erectile dysfunction in African Caribbean men: a pilot waitlist controlled randomised controlled trial and content analysis.
Limited clinical trials have evaluated the effectiveness of mindfulness for sexual functioning in men and the existing studies have targeted white male populations. The present study aimed to evaluate the effectiveness of a Mindfulness-Based Cognitive Intervention (MBCI) for erectile dysfunction (ED) in n=68 African Caribbean men aged 31–50 years old A mixed methods approach was adopted to establish the feasibility of a brief online MBCI, using a waitlist-controlled randomised trial with an experimental and delayed group and a content analysis. Participants completed a series of assessments measuring ED, sexual self-efficacy, well-being, and cognitive mindfulness at weeks 0, 4, and 12 (follow-up). They also completed a series of feedback questions on their experiences of the intervention at weeks 0, 4, and 12. Higher levels of erectile functioning, cognitive mindfulness, sexual self-efficacy, and well-being were reported post-intervention and at the 12-week follow-up. A content analysis of participant feedback responses yielded favourable outcomes, with participants suggesting that they continue to engage in cognitive mindfulness exercises to support them in “having better sex”. This research is the first to look at MCBI in African-Caribbean males with ED and demonstrated the effectiveness of this online intervention; however, it warrants replication with a larger group of ethnically and culturally diverse participants with ED.
- Open Access
A Systematic Review Exploring the Effectiveness of Mindfulness for Sexual Functioning in Women with Cancer
Sexual intimacy is a basic human need that is associated with quality of life whereby its absence can significantly impact both interpersonal and personal wellbeing. This systematic review aimed to provide an up-to-date evaluation of the available literature on mindfulness treatments for sexual functioning in women diagnosed with cancer. Electronic searches including PubMed, PsycINFO, Web of Science and registered clinical trials yielded 10 studies that met the inclusion criteria. The results showed that treatment intervention designs varied and included mixed methods, randomised clinical trials, single arm non-randomised trials and those with the absence of any control. Furthermore, both brief and longer-term mindfulness interventions were trialled across different sexual domains. Whilst inconclusive, mindfulness-based interventions appear to support sexual function and quality of life in both early- and post-cancer survivors. However, in some instances, there were outcome inconsistencies in sexual desire, arousal and orgasm. This review has identified a current shortage in research on the effectiveness of mindfulness-based treatments for supporting sexual functioning in women with cancer; and so far, no research has been conducted in palliative care. This unmet need in supporting sexual functioning in women with cancer, including palliative care, carries important implications for both psychosexual and oncological healthcare services as sexual intimacy does not end with cancer diagnosis or prognosis.
Open AccessA Systematic Review Exploring the Effectiveness of Mindfulness for Sexual Functioning in Women with Cancer
Sexual intimacy is a basic human need that is associated with quality of life whereby its absence can significantly impact both interpersonal and personal wellbeing. This systematic review aimed to provide an up-to-date evaluation of the available literature on mindfulness treatments for sexual functioning in women diagnosed with cancer. Electronic searches including PubMed, PsycINFO, Web of Science and registered clinical trials yielded 10 studies that met the inclusion criteria. The results showed that treatment intervention designs varied and included mixed methods, randomised clinical trials, single arm non-randomised trials and those with the absence of any control. Furthermore, both brief and longer-term mindfulness interventions were trialled across different sexual domains. Whilst inconclusive, mindfulness-based interventions appear to support sexual function and quality of life in both early- and post-cancer survivors. However, in some instances, there were outcome inconsistencies in sexual desire, arousal and orgasm. This review has identified a current shortage in research on the effectiveness of mindfulness-based treatments for supporting sexual functioning in women with cancer; and so far, no research has been conducted in palliative care. This unmet need in supporting sexual functioning in women with cancer, including palliative care, carries important implications for both psychosexual and oncological healthcare services as sexual intimacy does not end with cancer diagnosis or prognosis.
- Open Access
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 3474
Abstract 3474: Molecular subtypes characterize appendiceal adenocarcinoma genomic evolution and disease behavior
Appendiceal adenocarcinoma (AC) are rare gastrointestinal tumors that exhibit a heterogeneous spectrum of tumor histology and differentiation patterns. Personalized AC treatments are limited by the lack of robust histopathological or genomic predictors of disease behavior. We utilized the MSK IMPACT sequencing panel to profile genomic signature patterns in somatic mutations, copy number alterations, and germline mutations in a large curated dataset of patients with AC. We evaluated co-occurrence and clonality patterns between frequently altered genes in AC (RAS, GNAS, TP53) to establish five molecular subtypes of mucinous appendiceal adenocarcinoma (MAAP): RAS mutated-only, GNAS mutated, TP53 & KRAS mutated, TP53 mutated-only, and none (all wild-type). In multivariable Cox regression models, patients with RAS mutated-only tumors exhibit a nearly non-lethal disease course compared to other molecular subtypes, including TP53 mutated-only tumors (hazard ratio for death: 75.6, pCitation Format: Michael B. Foote, Henry Walch, Walid Chatila, Efsevia Vakiani, Chris Chandler, Felix Steinrucke, Garrett Nash, Zsofia Stadler, Sebastian Chung, Yelena Kemel, Anna Maio, Margaret Sheehan, Nikolaus Shultz, Luis A. Diaz, Andrea Cercek. Molecular subtypes characterize appendiceal adenocarcinoma genomic evolution and disease behavior [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3474.
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 3474
Open AccessAbstract 3474: Molecular subtypes characterize appendiceal adenocarcinoma genomic evolution and disease behavior
Appendiceal adenocarcinoma (AC) are rare gastrointestinal tumors that exhibit a heterogeneous spectrum of tumor histology and differentiation patterns. Personalized AC treatments are limited by the lack of robust histopathological or genomic predictors of disease behavior. We utilized the MSK IMPACT sequencing panel to profile genomic signature patterns in somatic mutations, copy number alterations, and germline mutations in a large curated dataset of patients with AC. We evaluated co-occurrence and clonality patterns between frequently altered genes in AC (RAS, GNAS, TP53) to establish five molecular subtypes of mucinous appendiceal adenocarcinoma (MAAP): RAS mutated-only, GNAS mutated, TP53 & KRAS mutated, TP53 mutated-only, and none (all wild-type). In multivariable Cox regression models, patients with RAS mutated-only tumors exhibit a nearly non-lethal disease course compared to other molecular subtypes, including TP53 mutated-only tumors (hazard ratio for death: 75.6, pCitation Format: Michael B. Foote, Henry Walch, Walid Chatila, Efsevia Vakiani, Chris Chandler, Felix Steinrucke, Garrett Nash, Zsofia Stadler, Sebastian Chung, Yelena Kemel, Anna Maio, Margaret Sheehan, Nikolaus Shultz, Luis A. Diaz, Andrea Cercek. Molecular subtypes characterize appendiceal adenocarcinoma genomic evolution and disease behavior [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3474.
- 15 June 2016
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 166, 21-25
The effect of alcohol dependence on automatic visuo-spatial perspective taking
- 15 June 2016
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 166, 21-25
The effect of alcohol dependence on automatic visuo-spatial perspective taking